PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
In: 10.1186/s13550-022-00932-9

Ereignis
Veröffentlichung
(wo)
Aachen
(wer)
Universitätsbibliothek der RWTH Aachen
(wann)
2022
Urheber
Ambur Sankaranarayana, Ramya
Florea, Alexandru
Allekotte, Susanne Maria
Vogg, Andreas
Maurer, Jochen
Schäfer, Laura
Bolm, Carsten
Terhorst, Steven
Classen, Arno
Bauwens, Matthias
Morgenroth, Agnieszka
Mottaghy, Felix

DOI
10.18154/RWTH-2022-09795
URN
urn:nbn:de:101:1-2023040507114484011305
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:49 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Ambur Sankaranarayana, Ramya
  • Florea, Alexandru
  • Allekotte, Susanne Maria
  • Vogg, Andreas
  • Maurer, Jochen
  • Schäfer, Laura
  • Bolm, Carsten
  • Terhorst, Steven
  • Classen, Arno
  • Bauwens, Matthias
  • Morgenroth, Agnieszka
  • Mottaghy, Felix
  • Universitätsbibliothek der RWTH Aachen

Entstanden

  • 2022

Ähnliche Objekte (12)

PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer

PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer

Correction: PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer

Correction: PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer

Correction : PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer

Correction : PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer

Auger emitter based endogenous therapy with an Olaparib derivative in triple negative breast cancer

Auger emitter based endogenous therapy with an Olaparib derivative in triple negative breast cancer

Multimodale Studien zum Arbeitsgedächtnis : Kombination von Positronenemissionstomographie (PET) und transkranieller Magnetstimulation (TMS)

Hochschulschrift

Multimodale Studien zum Arbeitsgedächtnis : Kombination von Positronenemissionstomographie (PET) und transkranieller Magnetstimulation (TMS)

Einfluß der fokalen transkraniellen Magnetstimulation auf die Bild-Benennlatenz bei Gesunden

Hochschulschrift

Einfluß der fokalen transkraniellen Magnetstimulation auf die Bild-Benennlatenz bei Gesunden

Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study

Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study

Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230

Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230

Is 68Ga-DOTA-FAPI a new arrow in the quiver of dose painting in radiation dose planning in head and neck cancers?

Is 68Ga-DOTA-FAPI a new arrow in the quiver of dose painting in radiation dose planning in head and neck cancers?

Is 68Ga-DOTA-FAPI a new arrow in the quiver of dose painting in radiation dose planning in head and neck cancers?

Is 68Ga-DOTA-FAPI a new arrow in the quiver of dose painting in radiation dose planning in head and neck cancers?

Special Issue : Emerging Technologies for Medical Imaging Diagnostics, Monitoring and Therapy of Cancers

Special Issue : Emerging Technologies for Medical Imaging Diagnostics, Monitoring and Therapy of Cancers

The battle on time, money and precision: Da[18F] id vs. [68Ga]liath

The battle on time, money and precision: Da[18F] id vs. [68Ga]liath

Verbundene Objekte